| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |